Participants' responsibilities in clinical research

Journal of Medical Ethics

Volumn 38, Issue 12, 2012, Pages 746-750

  Resnik, David B ^a   Ness, Elizabeth ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BENEFICENCE; CLINICAL TRIAL (TOPIC); DECEPTION; DECISION MAKING; ETHICS; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN RELATION; INCOME; INFORMED CONSENT; MALE; MORALITY; MOTIVATION; PATIENT COMPLIANCE; PERSONAL AUTONOMY; PERSUASIVE COMMUNICATION; PSYCHOLOGICAL ASPECT; RESEARCH SUBJECT; SOCIAL BEHAVIOR; STATISTICS;

ADULT; BENEFICENCE; CHOICE BEHAVIOR; CLINICAL TRIALS AS TOPIC; COERCION; DECEPTION; FEMALE; HUMAN EXPERIMENTATION; HUMANS; INCOME; INFORMED CONSENT; MALE; MEDICATION ADHERENCE; MORAL OBLIGATIONS; MOTIVATION; PERSONAL AUTONOMY; RESEARCH SUBJECTS; RESEARCHER-SUBJECT RELATIONS; SOCIAL RESPONSIBILITY;

EID: 84872273119     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2011-100319     Document Type: Article

References (39)

1. Gallin J. Principles and practice of clinical research. 2nd edn. Burlington, MA: Academic Press, 2007.
2. International Conference on Harmonization. Good clinical practice guidelines. http://ichgcp.net/ (accessed 1 Sep 2011).
3. Herrera CD. Universal compulsory service in medical research. Theor Med 2003;24:215-31.
4. Harris J. Scientific research is a moral duty. J Med Ethics 2005;31:242-8.
5. Rhodes R. Rethinking research ethics. Am J Bioeth 2005;5:7-28.
6. Schaefer GO, Emanuel EJ, Wertheimer A. The obligation to participate in biomedical research. JAMA 2009;302:67-72.
7. Edwards SJ. Research participation and the right to withdraw. Bioethics 2006;19:112-30.
8. Chwang E. Against the inalienable right to withdraw from research. Bioethics 2008;22:370-8.
9. McConnell T. The inalienable right to withdraw from research. J Law Med Ethics 2010;38:840-6.
10. Schaefer GO, Wertheimer A. The right to withdraw from research. Kennedy Inst Ethics J 2010;20:329-52.
11. Institute of Medicine (IOM). Responsible research: a systems approach to protecting human research participants. Washington, DC: National Academy Press, 2002. http://www.nap.edu/catalog.php?record_id=10508#toc (accessed 7 Oct 2011).
12. Veatch R. The patient as partner: a theory of human experimentation ethics. Bloomington, IN: Indiana University Press, 1987.
13. Beauchamp T, Childress J. Principles of biomedical ethics. 6th edn. New York: Oxford University Press, 2008.
14. Resnik DB. The patient's duty to adhere to prescribed treatment: an ethical analysis. J Med Phil 2005;30:167-88.
15. Pojman LP. Ethics: discovering right and wrong. 5th edn. Belmont, CA: Wadsworth, 2005.
16. Topol EJ. Failing the public health-Rofecoxib, Merck, and the FDA. N Engl J Med 2004;351:1707-9.
17. Creighton University. Research participants' rights and responsibilities. http://www.creighton.edu/researchcompliance/humanresearchprotectionprogram/researchparticipantinformation/researchparticipantsrightsandresponsibilities/index.php (accessed 2 Sep 2011).
18. Stanford University, Department of Psychology. Paid participant rights and responsibilities. 2011. https://psychology.stanford.edu/paidparticipantrights (accessed 2 Sep 2011).
19. University of Texas at Austin. Subject responsibilities. 2011. http://www.utexas.edu/research/rsc/humansubjects/participants/subject_responsibilities.html (accessed 2 Sep 2011).
20. Rabkin J, Small E. Rights and responsibilities of research participants. Body positive magazine, December 2001. http://www.thebody.com/content/art31134.html (accessed 2 Sep 2011).
21. Shamoo AS, Resnik DB. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. Am J Bioeth 2006;6:W1-13.
22. Vanderpool HY, Weiss GB. False data & the therapeutic misconception: two urgent problems in research ethics. False data and last hopes: enrolling ineligible patients in clinical trials. Hastings Cent Rep 1987;17:16-19.
23. Angell M, Kassirer J. Setting the record straight in the breast cancer trial. N Engl J Med 1994;330:1448-50.
24. Colfax G, Buchbinder S, Vamshidar G, et al. Motivations for participating in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr 2005;39:359-64.
25. Cassileth BR, Lusk EJ, Miller DS, et al. Attitudes toward clinical trials among patients and the public. JAMA 1982;248:968-70.
26. Appelbaum PS, Lidz CW, Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB 2004;26:1-8.
27. Abadie R. The professional Guinea pig: big pharma and the risky world of human subjects. Durham, NC: Duke University Press, 2010.
28. Resnik DB, Koski G. A national registry for healthy volunteers in phase 1 clinical trials. JAMA 2011;305:1236-7.
29. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acqui Immune Defic Syndr 2001;28:445-9.
30. Mannheimer S, Friedland G, Matts J, et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis 2002;34:1115-21.
31. Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy 2006;26:1111-33.
32. Gust DA, Mosimaneotsile B, Mathebula U, et al. Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana. PLoS One 2011;6: e18435.
33. Wertheimer A. Rethinking the ethics of clinical research: widening the lens. New York: Oxford University Press, 2011.
34. Mill JS. Utilitarianism and on liberty. New York: Wiley-Blackwell, 2003 [1859, 1863].
35. Sterling TR, Villarino ME, Borisov , et al. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011;365:2155-66.
36. Verma G, Upshur RE, Rea E, et al. Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives. BMC Med Ethics 2004;12:e2.
37. Kraemer JD, Cabrera OA, Singh JA, et al. Public health measures to control tuberculosis in low-income countries: ethics and human rights considerations. Int J Tuberc Lung Dis 2011;15(Suppl 2):S19-24.
38. Fidler DP, Gostin LO, Markel H. Through the quarantine looking glass: drug-resistant tuberculosis and public health governance, law, and ethics. J Law Med Ethics 2007;35:616-28.
39. Gostin LO. General justifications for public health regulation Public Health 2007;121:829-34.